MedDataX Logo

Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)

NCT ID: NCT01103089

Last Updated: 2011-10-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-03-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine patient characteristics from patients that have used Iressa for a period of minimal 3 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participation in the gefitinib Expanded Access Program
* Patient still uses gefitinib in September 2009
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Amsterdam, , Netherlands

Site Status

Research Site

Apeldoorn, , Netherlands

Site Status

Research Site

Groningen, , Netherlands

Site Status

Research Site

Helmond, , Netherlands

Site Status

Research Site

Hengelo, , Netherlands

Site Status

Research Site

Hoofddorp, , Netherlands

Site Status

Research Site

Leiden, , Netherlands

Site Status

Research Site

The Hague, , Netherlands

Site Status

Research Site

Veldhoven, , Netherlands

Site Status

Research Site

Venlo, , Netherlands

Site Status

Research Site

Zutphen, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-ONL-IRE-2009/1

Identifier Type: -

Identifier Source: org_study_id